Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES DAVID BIRD

Allopathic & Osteopathic Physicians Family Medicine

NPI
1134164718
CMS profile
323422
Location
COLORADO SPGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$1,394.69

90 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,394.69 90

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 90 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES DAVID BIRD

NPI 1134164718 · CMS profile ID 323422

Allopathic & Osteopathic Physicians / Family Medicine

COLORADO SPGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 90 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1134164718?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES DAVID BIRD, NPI 1134164718, CMS profile ID 323422. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 90 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1134164718?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). CHARLES DAVID BIRD, NPI 1134164718, CMS profile ID 323422. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 90 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1134164718?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
CHARLES DAVID BIRD, NPI 1134164718, CMS profile ID 323422, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 90 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1134164718?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

90 matching records · $1,394.69 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 90 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 90.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $13.9712/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662230849 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.1012/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271631 CMS
Lilly USA, LLC $11.0612/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657727745 CMS
Amarin Pharma Inc. $16.2312/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699266397 CMS
Amgen Inc. $13.8212/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662230839 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $9.2612/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271653 CMS
Biogen, Inc. $19.2611/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703093173 CMS
GlaxoSmithKline, LLC. $24.3611/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671146529 CMS
Lilly USA, LLC $11.6911/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657727743 CMS
Lilly USA, LLC $9.0511/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657713747 CMS
SANOFI-AVENTIS U.S. LLC $15.6711/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694290991 CMS
AstraZeneca Pharmaceuticals LP $20.5211/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686013033 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.3111/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271633 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.6010/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271635 CMS
Lilly USA, LLC $10.1210/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657720775 CMS
Horizon Therapeutics plc $18.1410/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691333965 CMS
Lilly USA, LLC $10.5310/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657710349 CMS
E.R. Squibb & Sons, L.L.C. $11.9710/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651282809 CMS
Amarin Pharma Inc. $24.7110/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699227141 CMS
Amgen Inc. $12.2110/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662230847 CMS
Janssen Pharmaceuticals, Inc $24.0109/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658333611 CMS
Allergan Inc. $13.1209/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670126235 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.1308/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271637 CMS
Janssen Pharmaceuticals, Inc $23.7008/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658333609 CMS
AstraZeneca Pharmaceuticals LP $21.5908/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685703545 CMS
Amgen Inc. $14.5808/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662230837 CMS
Lilly USA, LLC $10.5308/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657703377 CMS
SANOFI-AVENTIS U.S. LLC $19.7008/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694085941 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.5308/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271639 CMS
AstraZeneca Pharmaceuticals LP $11.3108/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686006289 CMS
Astellas Pharma US Inc $17.7608/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655472821 CMS
SANOFI-AVENTIS U.S. LLC $15.7607/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694116067 CMS
Janssen Pharmaceuticals, Inc $17.1607/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658333597 CMS
Vertiflex, Inc. $12.2907/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669453853 CMS
Lilly USA, LLC $10.9607/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657717301 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.7607/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700271641 CMS
E.R. Squibb & Sons, L.L.C. $14.9507/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651282789 CMS
GlaxoSmithKline, LLC. $23.6006/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671549611 CMS
Amgen Inc. $12.9006/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662230845 CMS
Lilly USA, LLC $8.9506/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657720773 CMS
Merck Sharp & Dohme Corporation $13.3306/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695897190 CMS
AstraZeneca Pharmaceuticals LP $11.5706/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685560385 CMS
Nevro Corp. $29.1506/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679665757 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.5906/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700049367 CMS
Astellas Pharma US Inc $23.3505/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655472817 CMS
Lilly USA, LLC $12.5005/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657727747 CMS
Mannkind Corporation $14.7705/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705561687 CMS
Nevro Corp. $24.4505/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679665761 CMS
E.R. Squibb & Sons, L.L.C. $16.4505/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651282787 CMS
Janssen Pharmaceuticals, Inc $14.5105/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658333583 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,394.69 90
PY2020 $1,170.35 74
PY2021 $711.88 41
PY2022 $313.84 16
PY2023 $234.89 12
PY2024 $117.47 6
PY2025 $1,476.69 9

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $57,441.29 25
PY2024 Recipient $19.04 1
PY2024 Principal investigator $46,820.62 4
PY2023 Recipient $1,663.33 1
PY2023 Principal investigator $74,844.03 3
PY2022 Principal investigator $211,918.24 9
PY2021 Principal investigator $4,140.48 4
PY2020 Principal investigator $31,575.18 8
PY2019 Principal investigator $45,192.87 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $559.80 12/31/2020 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH N01 MIDCO N01 LTD
A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with moderately to Severely Active Croh No dispute reported 06/30/2026 721316169
Principal investigator 1 Allergan, Inc. $500.94 12/31/2020 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH N01 MIDCO N01 LTD
A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double- Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis No dispute reported 06/30/2026 721316197
Principal investigator 1 AstraZeneca Pharmaceuticals LP $3,006.81 12/31/2020 Non-covered Recipient Entity
Clinical Research Advantage Inc
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 736742433
Principal investigator 1 Amgen Inc. $1,850.00 08/31/2020 Non-covered Recipient Entity
RADIANT RESEARCH - COLORADO SPRINGS FAMILY PRACTICE
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 731634623
Principal investigator 1 Eli Lilly and Company $1,098.73 06/25/2020 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 728737797
Principal investigator 1 Amgen Inc. $2,808.00 03/20/2020 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 731634767
Principal investigator 1 Amgen Inc. $2,808.00 01/30/2020 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 731634093
Principal investigator 1 AstraZeneca Pharmaceuticals LP $18,942.90 01/02/2020 Non-covered Recipient Entity
Clinical Research Advantage Inc
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 736737157